BiotechTube
Biocheck

Biocheck

San Francisco, United States· Est.
biocheckinc.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $99K

Overview

BioCheck is a commercial-stage, private diagnostics company with a global footprint following its 2021 acquisition of DRG International. Its core business involves the development, manufacturing, and global distribution of immunoassay-based diagnostic tests and automated analyzers. The company's strategy emphasizes value-based diagnostics, data monetization, and healthcare shared savings to align incentives and improve care delivery. BioCheck leverages its DRG subsidiaries for manufacturing, R&D, and distribution across North America, Europe, and Russia.

EndocrinologyDiabetesPrenatal/NeonatalThyroid FunctionCardiologyInfectious Diseases

Technology Platform

Immunoassay development (ELISA, chemiluminescence) and automated analyzer systems (HYBRiD-XL®) for clinical diagnostics.

Funding History

1
Total raised:$99K
Grant$99K

Opportunities

The global shift towards value-based healthcare creates demand for cost-effective diagnostics that improve patient outcomes, aligning with BioCheck's core messaging.
Its acquisition of DRG International provides immediate scale, a broader product portfolio, and direct access to established distribution networks in over 110 countries, including growing markets in Eastern Europe.

Risk Factors

Significant exposure to geopolitical and operational risk due to substantial subsidiary operations in Russia and Eastern Europe.
The company faces intense competition from large, established diagnostics corporations and must successfully integrate the acquired DRG businesses to realize synergies and manage a complex global structure.

Competitive Landscape

BioCheck competes in the crowded immunoassay segment of the IVD market, dominated by multinational giants like Roche, Abbott, Siemens, and Danaher. It differentiates through a focus on value-based care and a mid-market position, but must compete on price, quality, service, and menu breadth against these well-resourced competitors and other specialized firms.

More companies in Diagnostics & Precision Medicine →More companies in United States →